Advances in diagnosis and treatment of large granular lymphocyte syndrome

Current Opinion in Hematology

Volumn 18, Issue 1, 2011, Pages 55-62

  Prochorec Sobieszek, Monika ^a,b  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Cytotoxic T cells; Large granular lymphocyte syndrome; Lymphoproliferative disorder; Natural killer cells; Neutropenia

Indexed keywords

ALEMTUZUMAB; BORTEZOMIB; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MIK BETA 1; NATURAL KILLER CELL RECEPTOR; PENTOSTATIN; PREDNISONE; PURINE DERIVATIVE; SIPLIZUMAB; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; TIPIFARNIB; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; B CELL LYMPHOMA; BONE MARROW; CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NATURAL KILLER CELL; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CYTOPENIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LARGE GRANULAR LYMPHOCYTE SYNDROME; LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR DIAGNOSIS; MONITORING; MORPHOLOGY; NATURAL KILLER CELL; NATURAL KILLER CELL LEUKEMIA; PALLIATIVE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; T CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA; T CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; LEUKOPENIA; LYMPHOPROLIFERATIVE DISORDERS; T-LYMPHOCYTES;

EID: 79851507941     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328340dc12     Document Type: Article

References (89)

1. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82:1-14. (Pubitemid 23188739)
2. Morice WG. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. Am J Clin Pathol 2007; 127:881-886.
3. Chan WC, Foucar K, Morice WG, Catovsky D. T-cell large granular lymphocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp. 272-273.
4. Villamor N, Morice WG, Chan WC, Foucar F. Chronic lymphoproliferative disorders of NK cells. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp. 274-275.
5. Chan JKC, Jaffe ES, Ralfkiaer E, Ko YH. Aggressive NK-cell leukaemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp. 276-277.
6. Zhang R, Shah MV, Loughran TP Jr. The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematol Oncol 2009; 28:105-117.
7. Semenzato G, Zambello R, Starkebaum G, et al. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89:256-260. (Pubitemid 26428200)
8. Pandolfi F, Loughran TP Jr, Starkebaum G, et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 1990; 65:341-348. (Pubitemid 20035364)
9. Dhodapkar MV, Li CY, Lust JA, et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994; 84:1620-1627. (Pubitemid 24273033)
10. Neben MA, Morice WG, Tefferi A. Clinical features in T-cell vs. natural killercell variants of large granular lymphocyte leukemia. Eur J Haematol 2003; 71:263-265. (Pubitemid 37174697)
11. Bareau B, Rey J, Hamidou M, et al. Analysis of the french LGL leukemia cohort: report on 229 cases. Heamatologica 2010; 95:1534-1541.
12. Shah A, Diehl LF, St Clair EW. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia. Clin Immunol 2009; 132:145-152.
13. Kwong YL, Au WY, Leung AY, Tse EW. T-cell large granular lymphocyte leukemia: an Asian perspective. Ann Hematol 2010; 89:331-339.
14. Yang J, Epling-Burnette PK, Painter JS, et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008; 111:1610-1616. (Pubitemid 351213452)
15. Morice WG, Kurtin PJ, Leibson PJ, et al. Demonstration of aberrantT-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Heamatol 2003; 120:1026-1036. (Pubitemid 36411562)
16. Lundell R, Hartung L, Hill S, et al. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 2005; 124:937-946. (Pubitemid 41740195)
17. Alekshun TJ, Tao J, Sokol L. Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature. Am J Hematol 2007; 82:481-485. (Pubitemid 46849323)
18. + large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. Am J Pathol 2003; 163:763-771. (Pubitemid 36909437)
19. Olteanu H, Karandikar NJ, Eshoa C, Kroft SH. Laboratory findings in CD4+ large granular lymphocytoses. Int J Lab Hematol 2010; 32:e9-e16.
20. Bourgault-Rouxel AS, Loughran TP Jr, Zambello R, et al, Clinical spectrum of γ δ+ T cell LGL leukemia: analysis of 20 cases. Leuk Res 2008; 32: 45-48. (Pubitemid 350100843)
21. Ryan DK, Alexander HD, Morris TC. Routine diagnosis of large granular lymphocytic leukaemia by Southern blot and polymerase chain reaction analysis of clonal T cell receptor gene rearrangement. Mol Pathol 1997; 50:77-81. (Pubitemid 27455007)
22. Roden AC, Morice WG, Hanson CA. Immunophenotypic attributes of benign peripheral blood γδ T cells and conditions associated with their increase. Arch Pathol Lab Med 2008; 132:1774-1780.
23. Feng B, Jorgensen JL, Hu Y, et al, TCR-Vβ flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia. J Clin Pathol 2010; 63:141-146.
24. + large granular lymphocytes. Am J Pathol 2001; 159:1861-1868.
25. Moura J, Rodrigues J, Santos AH, et al, Chemokine receptor repertoire reflects mature T-cell lymphoproliferative disorder clinical presentation. Blood Cells Mol Dis 2009; 42:57-63.
26. Huh YO, Medeiros LJ, Ravandi F, et al, T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases. Am J Clin Pathol 2009; 131:347-356.
27. Subbiah V, Viny AD, Rosenblatt S, et al, Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. Exp Hematol 2008; 36:1078-1083.
28. Viny AD, Lichtin A, Pohlman B, et al, Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leuk Lymphoma 2008; 49:932-938. (Pubitemid 351942747)
29. Howard MT, Bejanyan N, Maciejewski JP, Hsi ED. T/NK large granular lymphocyte leukemia and coexisting monoclonal B-cell lymphocytosis-like proliferations. An unrecognized and frequent association. Am J Clin Pathol 2010; 133:936-941.
30. + lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci 2009; 14:3771-3781.
31. + lymphocytes in HIV infection. J Clin Pathol 2000; 53:177-181. (Pubitemid 30163598)
32. + T-cell large granular lymphocytes after primary cytomegalovirus infection. Am J Heamatol 2007; 82:1103-1105. (Pubitemid 350209855)
33. + T cell population of rheumatoid arthritis patients. J Immunol 1996; 156:852-858.
34. Prochorec-Sobieszek M, Rymkiewicz G, Makuch-Łasica H, et al, Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy. Arthritis Res Ther 2008; 10:R55.
35. Epling-Burnette PK, Painter JS, Rollison DE, et al, Prevalence and clinical association of clonal T-cell expansions in myelodysplastic syndrome. Leukemia 2007; 21:659-667. (Pubitemid 46444549)
36. Li Y, Yang L, Chen S, et al, The TCR Vβ repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen. Hematology 2005; 10:387-392. (Pubitemid 41806528)
37. Raitakari M, Brown RD, Sze D, et al, T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells. Br J Haematol 2000; 110:203-209. (Pubitemid 30625609)
38. Baseggio L, Regad AL, Ffrench M, Felman P. Simultaneous detection of clonal expansion of large granular lymphocytes and breast cancer in blood. Leuk Res 2010; 34:e304-e305.
39. Mohty M, Faucher C, Vey N, et al, Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis. Leukemia 2002; 16:2129-2133. (Pubitemid 35203458)
40. Sabnani I, Zucker MJ, Tsang P, Palekar S. Clonal T-large granular lymphocyte proliferation in solid organ transplant recipients. Transplant Proc 2006; 38:3437-3440. (Pubitemid 44908432)
41. Ramesh M, Al-Kadhimi Z, Mellon-Reppens S, et al, T-cell large granular lymphocyte (T-LGL) expansion post adult allogeneic hematopoietic stem cell transplantation (HSCT): a prognostic indicator for improved overall survival. Blood 2009; 114:883-884.
42. Bigouret V, Hoffmann T, Arlettaz L, et al, Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 2003; 101:3198-3204. (Pubitemid 36858015)
43. Wlodarski MW, Nearman Z, Jiang Y, et al, Clonal predominance of CD8+ T cells in patients with unexplained neutropenia. Exp Hematol 2008; 36:293-300. (Pubitemid 351221173)
44. Kreutzman A, Juvonen V, Kairisto V, et al, Mono/oligoclonal T- and NK-cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy. Blood 2010; 116:772-782.
45. Kim DH, Kamel-Reid S, Chang H, et al, Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia. Haematologica 2009; 94:135-139.
46. Mustjoki S, Ekblom M, Arstila TP, et al, Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia 2009; 23:1398-1405.
47. Nagata Y, Ohashi K, Fukuda S, et al, Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion. Int J Hematol 2010; 91:799-807.
48. -/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004; 165:1117-1127. (Pubitemid 39297719)
49. Morice WG, Jevremovic D, Olteanu H, et al, Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets. Leukemia 2010; 24:881-884.
50. Fronková E, Krejcí O, Kalina T, et al, Lymphoid differentiation pathways can be traced by TCRδ rearrangements. J Immunol 2005; 175:2495-2500. (Pubitemid 41113860)
51. Suzuki R, SuzumiyaJ, Nakamura S, et al, Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004; 18:763-770. (Pubitemid 38500195)
52. Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 2006; 20:245-266. (Pubitemid 44209204)
53. Liu JH, Wei S, Lamy T, et al, Chronic neutropenia mediated by fas ligand. Blood 2000; 95:3219-3222. (Pubitemid 30321177)
54. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 85:3183-3190.
55. + Vδ1/Vβ16 T cells in a patient with chronic neutropenia. Scand J Immunol 2003; 58:89-98. (Pubitemid 36819202)
56. Wlodarski MW, O'Keefe C, Howe EC, et al, Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 2005; 106:2769-2780. (Pubitemid 41510753)
57. Viny A, Clemente MJ, Jasek M, et al, MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia. Haematologica 2010; 95:1713-1721.
58. Wolfrom CM, Lévy V, Deschatrette J. Neutropenia dynamics in a case of T-LGL lymphoproliferation illustrate rapid turnover of granulocyte progenitors. Cell Prolif 2010; 43:326-332.
59. + large granular lymphocyte leukemia. Blood 1998; 92:4771-4777. (Pubitemid 29005880)
60. Shah MV, Zhang R, Loughran TP Jr. Never say die: survival signaling in large granular lymphocyte leukemia. Clin Lymphoma Myeloma 2009; 9 (Suppl 3): S244-S253.
61. Zhang R, Shah MV, Yang J, et al, Network model of survival signaling in large granular lymphocyte leukemia. Proc Natl Acad Sci U S A 2008; 105:16308-16313.
62. Schade AE, Powers JJ, Wlodarski MW, Maciejewski JP. Phosphatidylinositol- 3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 2006; 107:4834-4840. (Pubitemid 43882635)
63. Schade AE, Wlodarski MW, Maciejewski JP. Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3K signaling in leukemic large granular lymphocytes. Cell Cycle 2006; 5:2571-2574. (Pubitemid 44785798)
64. Shah MV, Zhang R, Irby R, et al. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 2008; 112:770-781.
65. Yang J, Liu X, Nyland SB, et al. Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood 2010; 115:51-60.
66. + lymphocyte survival. J Immunol 2010; 184:5582-5588.
67. Sokol L, Agrawal D, Loughran TP Jr. Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia. Leuk Res 2005; 29:381-387. (Pubitemid 40255811)
68. Thomas A, Perzova R, Abbott L, et al. LGL leukemia and HTLV. AIDS Res Hum Retroviruses 2010; 26:33-40.
69. -/+ dim T-LGL lymphocytosis recognize hCMV antigens. Blood 2008; 112:4609-4616.
70. Zambello R, Falco M, Della Chiesa M, et al. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood 2003; 102:1797-1805. (Pubitemid 37022576)
71. Epling-Burnette PK, Painter JS, Chaurasia P, et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004; 103:3431-3439. (Pubitemid 38525675)
72. Gattazzo C, Miorin M, Scquizzato E, et al. Lack of expression of inhibitory KIR3DL1 receptor in patients with NK-type lymphoproliferative disease of granular lymphocytes. Haematologica 2010; 95:1722-1729.
73. Yu J, Ershler M, Yu L, et al. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. Blood 2009; 113:5558-5567.
74. Balsamo M, Zambello R, Teramo A, et al. Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30. Exp Hematol 2009; 37:1167-1175.
75. Epling-Burnette PK, Bai F, Wei S, et al. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 2004; 23:9220-9229. (Pubitemid 40069692)
76. Epling-Burnette PK, Sokol L, Chen X, et al. Clinical improvement by farnesyl- transferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood 2008; 112:4694-4698.
77. Osuji N, Matutes E, Tjonnfjord G, et al. T-cell large granular lymphocyte leukemia. A report on the treatment of 29 of patients and a review of the literature. Cancer 2006; 107:570-578. (Pubitemid 44107218)
78. Pawarode A, Wallace PK, Ford LA, et al. Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia. Leuk Lymphoma 2010; 51:338-341.
79. Fortune AF, Kelly K, Sargent J, et al. Large granular lymphocyte leukemia: natural history and response to treatment. Leuk Lymphoma 2010; 51:839-845.
80. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994; 84:2164-2170. (Pubitemid 24296373)
81. Fujishima N, Sawada K, Hirokawa M, et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 2008; 93:1555-1559.
82. Dincol G, Diz-Kuçukkaya R, Bicakci E. T-cell large granular lymphocytic leukaemia: successful response to 2-deoxycoformycin. Neth J Med 2008; 66:85-87. (Pubitemid 351279452)
83. Tse E, Chan JC, Pang A, et al. Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia. Leukemia 2007; 21:2225-2226. (Pubitemid 47423825)
84. Sretenovic A, Antic D, Jankovic S, et al. T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience. Med Oncol 2010; 27:286-290.
85. + large granular lymphocyte leukemia. Haematologica 2009; 94:1407-1414.
86. Monjanel H, Hourioux C, Arbion F, et al. Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment. Leuk Res 2010; 34:e197-e199.
87. Rosenblum MD, LaBelle JL, Chang CC, et al. Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia. Blood 2004; 103:1969-1971. (Pubitemid 38269004)
88. O'Mahony D, Morris JC, Stetler-Stevenson M, et al. EBV-related lymphopro- liferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. Clin Cancer Res 2009; 15:2514-2522.
89. Shen L, Au WY, Guo T, Wong KY, et al. Proteasome inhibitor bortezomibinduced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation. Blood 2007; 110:469-470. (Pubitemid 47026871)